Fundamental - Factsheet
Help
Clearbridge
CLEARBRIDGE HEALTH LIMITED
Quotes 10 Minutes Delayed. Updated at 22 Sep 2020 12:00
| Last (SGD): 0.153 |
Change: - |
High: 0.155 |
| Change (%): - |
Low: 0.152 |
| Open |
0.153 |
Yesterday's Close |
0.153 |
| Buy Price |
0.152 |
Sell Price |
0.153 |
| Buy Volume ('000) |
365.0 |
Sell Volume ('000) |
8.9 |
| Cumulative Volume ('000) |
645.3 |
Cumulative Value |
98,505 |
Latest News
-
26 Aug 2020 08:47
-
23 Aug 2020 18:15
-
19 Aug 2020 18:11
-
17 Aug 2020 10:14
-
14 Aug 2020 19:01
-
14 Aug 2020 19:00
-
24 Jul 2020 18:31
-
16 Jul 2020 18:37
View All News
Key Statistics
|
(SGD) a
|
-0.01732 |
(SGD) e |
-0.00983 |
(SGD) b |
0.1015 |
| a
|
- |
f |
- |
b |
1.5074 |
|
(SGD) d
|
- |
Cash In Hand
(SGD) g |
0.0219 |
Issued & Paid-up Shares
c |
609,199,000 |
| (%)
d
|
- |
Price / Cash In Hand
g |
6.986 |
Treasury Shares h |
- |
| - 75
Daysi |
0.673 |
- 75
Days(%)i |
4.92 |
Market Cap (M) |
93.207 |
| - 500
Daysi |
0.887 |
- 500 Days
(%)i |
5.54 |
Enterprise Value (M) |
89.467 |
|
1 |
Exchange Code |
1H3 |
Par Value (
SGD
)
|
n.a. |
| 52 Weeks Volatility (%) |
58.9882 |
6-Month VWAP |
0.209 |
|
51.6 |
| Under CPF Investment Scheme (CPFIS) |
No |
| Sector & Industry |
Health and Social Services
-
Medical/Nursing Services |
Notes:
-
Based on latest Full Year results announcement, adjusted for the current number of shares.
-
Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
-
-
Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
-
Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
-
Based on Trailing EPS.
-
Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
-
Rounded to the nearest thousand.
-
Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.
Peer Comparison
| Type |
Name |
Market |
Market Cap (M)a |
b
|
c
|
d
|
(%)d
|
| Reference |
Clearbridge |
SGX |
93.207 |
- |
- |
1.5074 |
- |
| Industry |
Medical/Nursing Services
|
SGX |
50.628 |
53.468 |
35.256 |
1.4117 |
2.787 |
| Local Peer |
Cordlife |
SGX |
92.923 |
14.359 |
12.126 |
0.7037 |
2.733 |
| Local Peer |
Asian Healthcare |
SGX |
85.715 |
29.889 |
34.177 |
2.0502 |
4.943 |
| Local Peer |
HC Surgical |
SGX |
46.824 |
13.385 |
13.386 |
2.8757 |
6.431 |
| Local Peer |
Alliance HC |
SGX |
37.212 |
15.939 |
15.937 |
2.0112 |
1.899 |
| Local Peer |
Sing Paincare |
SGX |
30.708 |
16.351 |
16.352 |
2.8963 |
0.002 |
| Local Peer |
Medinex |
SGX |
25.586 |
7.037 |
7.037 |
1.7939 |
8.615 |
| Local Peer |
AsiaMedic |
SGX |
25.749 |
- |
- |
2.4211 |
- |
| Local Peer |
RHT HealthTrust |
SGX |
15.417 |
- |
- |
0.9223 |
- |
| Global Peer |
FRESENIUS MEDICAL CARE AG & CO KGAA SPON ADR-EACH REP 0.5 NPV |
NYSE |
25,203.266 |
18.771 |
17.411 |
1.8506 |
1.178 |
| Global Peer |
PA GOODDOCTOR |
HKEx |
119,643.209 |
- |
- |
11.5133 |
- |
| Global Peer |
SONIC HEALTHCARE |
ASX |
15,883.796 |
30.097 |
30.097 |
2.8498 |
2.543 |
| Global Peer |
DAVITA INC |
NYSE |
10,384.640 |
12.805 |
12.674 |
4.8213 |
- |
| Global Peer |
GUARDANT HEALTH INC |
NASDAQ |
10,605.590 |
- |
- |
9.5153 |
- |
| Global Peer |
CHEMED CORP |
NYSE |
7,633.575 |
34.710 |
29.078 |
10.1687 |
0.259 |
| Global Peer |
AMEDISYS INC |
NASDAQ |
7,799.800 |
61.497 |
60.811 |
10.8203 |
- |
| Global Peer |
LHC GROUP INC |
NASDAQ |
6,335.099 |
66.180 |
53.422 |
4.2885 |
- |
| Global Peer |
INVITAE CORP |
NYSE |
5,358.935 |
- |
- |
11.5447 |
- |
| Global Peer |
NATERA INC |
NASDAQ |
5,275.260 |
- |
- |
17.3375 |
- |
| Other Global Peers |
SMILEDIRECTCLUB INC (NASDAQ), NEOGENOMICS INC (NASDAQ), 1LIFE HEALTHCARE INC (NASDAQ), JXR (HKEx), ENSIGN GROUP INC (NASDAQ), ACADIA HEALTHCARE (NASDAQ), OPTION CARE HEALTH INC (NASDAQ), BURNING ROCK BIOTECH LTD SPON ADS EACH REP 1 ORD SHS CL A (NASDAQ), MEDNAX INC (NYSE), ADDUS HOMECARE CORP (NASDAQ), HEALIUS LTD (ASX), SVH (SET), US PHYSICAL THERAPY (NYSE), ONTRAK INC (NASDAQ), RAM (SET), PENNANT GROUP INC (NASDAQ), GENETRON HOLDINGS LIMITED SPON ADS EACH REP 5 ORD SHS (NASDAQ), CASTLE BIOSCIENCES INC (NASDAQ), C-MER EYE (HKEx), KPJ (Bursa), Metro Healthcare Indonesia Tbk. (IDX), RADNET INC (NASDAQ), FULGENT GENETICS INC (NASDAQ), OAK STREET HEALTH INC (NYSE), HANGER INC (NYSE), TIVITY HEALTH INC (NASDAQ), TOWN HEALTH (HKEx), UM HEALTHCARE (HKEx), GLOBAL CORD BLOOD CORPORATION (NYSE), OCEANIA HEALTHCARE LTD (ASX), PROGENITY INC (NASDAQ), CLOVER CORP (ASX), EUROEYES (HKEx), OPTINOSE INC (NASDAQ), AMERICAN RENAL ASSOCS HLDGS INC (NYSE), VIRTUS HEALTH LIMITED (ASX), AKUMIN INC (NASDAQ), CARDIFF ONCOLOGY INC (NASDAQ), APTINYX INC (NASDAQ), CRH MEDICAL CORP (NYSE American), EXAGEN INC (NASDAQ), KANGHUA HEALTH (HKEx), ONCOSEC MEDICAL INCORPORATED (NASDAQ), PRO-DEX INC (NASDAQ), UMP (HKEx), AESTHETIC MEDICAL INT HLDGS GRP LTD SPON ADS EACH REP 3 ORD SHS (NASDAQ), BIOCEPT INC (NASDAQ), CONCORD MEDICAL SERVICES HLDGS LTD ADS EACH 1 REPR 3 ORD SHS (USD0.0001) (NYSE), ORTHOCELL LIMITED (ASX), KDH (SET), MHCARE (Bursa), BARD1 LIFE SCIENCES LTD (ASX), HEALTHIA LTD (ASX), HUMAN HEALTH (HKEx), TOTAL BRAIN LTD (ASX), RMH HOLDINGS (HKEx), D (SET), CHINA HEALTH (HKEx), CAPITAL SENIOR LIVING CORP (NYSE), REPUBLIC HC (HKEx), GUARDION HEALTH SCIENCES INC (NASDAQ), WAH YAN-OLD (HKEx), WAH YAN-NEW (HKEx), SMILE (Bursa), AMERICAN SHARED HOSPITAL SERVICES (NYSE American), IMAC HOLDINGS INC (NASDAQ), MEDINET GROUP (HKEx), MOHO RESOURCES NL (ASX), SMILES INCLUSIVE LTD (ASX), LIFESPOT HEALTH LTD (ASX), TOPVISN (Bursa) |
Notes:
-
For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is
the average market cap for that industry/index.
-
Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the
industry/index.
-
Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all
companies in the industry/index.
-
Industry/Index Dividend Yield is
calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
-
For Industry/Index calculation, data for foreign currency denominated companies will be converted to the
main market currency using the latest exchange rate.
-
Industry/Index/Peers data is updated daily.
-
Peers are sorted by market capitalisation and only details for the top 10 will be shown.
Total Shareholder Return
| Period | Dividend Received | Capital Appreciation | Total Shareholder Return |
|---|
| Short Term Return |
5 Days |
- | -0.005 | | | -3.16 % |
| 10 Days |
- | -0.012 | | | -7.27 % |
| 20 Days |
- | -0.025 | | | -14.04 % |
| Medium Term Return |
3 Months |
- | -0.042 | | | -21.54 % |
| 6 Months |
- | +0.052 | | | +51.49 % |
| 1 Year |
- | +0.011 | | | +7.75 % |
| Long Term Return |
2 Years |
- | -0.097 | | | -38.80 % |
| Annualised Return |
Annualised |
- | - | | | -21.77 % |
Notes:
-
Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
-
Script dividends are ignored in this calculation.
Price Movements
| 1 Year Range |
0.094 - 0.390 |
Change From 1 Year Low |
+0.059 |
% Change From 1 Year Low (%) |
+62.77 |
| Change From 1 Year High |
-0.237 |
% Change From 1 Year High (%) |
-60.77 |
| 2 Years Range |
0.094 - 0.390 |
Change From 2 Years Low |
+0.059 |
% Change From 2 Years Low (%) |
+62.77 |
| Change From 2 Years High |
-0.237 |
% Change From 2 Years High (%) |
-60.77 |
| 5 Years Range |
0.094 - 0.630 |
Change From 5 Years Low |
+0.059 |
% Change From 5 Years Low (%) |
+62.77 |
| Change From 5 Years High |
-0.477 |
% Change From 5 Years High (%) |
-75.71 |
Notes:
Price movements are based on adjusted historical data.
Company Background
Clearbridge Health Limited is a healthcare company with a focus on the delivery of precision medicine in Asia. The Group’s vision is to empower clinicians and healthcare professionals to make more reliable and accurate diagnoses, provide insights to disease management and tailor personalised prevention and timely treatment programmes for patients. The Group’s technology agnostic approach allows it to adopt the most appropriate technology in each segment of its business and the products and/or services it offers.The Group’s business comprises (a) provision of laboratory testing services; (b) ownership and operation of medical clinics/centres; and (c) strategic equity participation in precision medical technology companies which complement its business objectives.
More Information Available
More information is available to our subscribers, including:
- Market Moving News from Dow Jones Newswires
- Consensus Estimates
- Dividend/Distribution History
- Financial Summary with Financial Period Comparison
- Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
- Events Calendar for Results Announcements, Ex-Dates etc
- Insider Buying and Selling Report
If you are an existing subscriber, please login. If not, read up on what
you are missing out in our Help Centre
and join us as a subscriber.
Disclaimer:
While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-
- no liability is accepted for any errors or inaccuracies resulting from your use of these features;
- many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
Login
Loading search items...
